SOHO State of the Art Updates and Next Questions | Venetoclax + Obinutuzumab Therapy in Chronic Lymphocytic Leukemia

Lipsky, A. H., & Lamanna, N. (2024). SOHO State of the Art Updates and Next Questions | Venetoclax + Obinutuzumab Therapy in Chronic Lymphocytic Leukemia. Clinical Lymphoma Myeloma and Leukemia. https://doi.org/10.1016/j.clml.2024.11.016
Authors:
Andrew H Lipsky
Nicole Lamanna
Affiliated Authors:
Andrew H Lipsky
Nicole Lamanna
Columbia Affiliation:
Author Keywords:
cll
mrd
targeted therapy
time-limited therapy
time-off-treatment
elink
Publication Type:
Article
Unique ID:
10.1016/j.clml.2024.11.016
PMID:
39732538
DOI:
10.1016/j.clml.2024.11.016
Journal:
Clinical Lymphoma, Myeloma and Leukemia
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: